Insurance medicine summit 2017
| Date | 15 - 17 Nov 2017 |
|---|---|
| Location | Centre for Global Dialogue Rüschlikon, Zurich, Switzerland Click to open Google Map |
Tab navigation
tab1
|
Wednesday, 15 November 2017 |
|
|
12.00 |
Lunch buffet |
|
13.00 |
ECG challenges: Learnings, discussions and case reviews |
|
16.30 |
End of course |
|
18.00 |
Welcome address and opening remarks |
|
18.05 |
Opening presentations
|
|
19.15 |
Welcome dinner |
This event may be photographed, filmed and/ or recorded. A summary of the event, pictures and/or a video of the event in which you may appear may be posted and made available on Swiss Re’s and the Swiss Re Institute's internal and external websites and in printed materials.
tab2
|
Thursday, 16 November 2017 |
|
|
08.00 |
Coffee and networking |
|
09.00 |
Welcome and introduction |
|
|
THEME I: The metabolic pandemic |
|
09.10 |
The obesity epidemic
|
|
09.45 |
New paradigms of type 2 diabetes
|
|
10.20 |
Panel discussion on nutrition and diabetes |
|
11.00 |
Coffee break |
|
|
|
|
|
THEME II: Lifestyle, risks and new technologies |
|
11.30 |
Session 1: Deep learning applications in medicine & insurance
Session 2: Predictive modelling developments in the US market
Session 3: Smoking, e-cigarettes, reduced-risk products Session 4: Wearables & apps: Tracking health vitals
|
|
12.00 |
Breakouts repeated - round 2 |
|
12.40 |
Lunch |
|
|
THEME III: Cardiovascular diseases |
|
14.00 |
The lipid debate: What's new?
|
|
14.30 |
Cardiac tests in underwriting: What tests? Who? When? Why?
|
|
|
THEME IV: A new era in cancer diagnostics and therapies |
|
15.00 |
Liquid biopsies and the future of cancer detection
|
|
15.30 |
Latest immune therapy approaches: BITE, CAR-T and checkpoint inhibitors
|
|
16.00 |
Coffee break |
|
16.30 |
Panel discussion: How will liquid biopsy and new therapeutics affect product definitions and design Panellists: |
|
17.15 |
Closing remarks |
|
17.20 |
Apero and networking |
|
18.15 |
Dinner |
This event may be photographed, filmed and/ or recorded. A summary of the event, pictures and/or a video of the event in which you may appear may be posted and made available on Swiss Re’s and the Swiss Re Institute's internal and external websites and in printed materials.
tab3
|
Friday, 17 November 2017 |
|
|
08.00 |
Coffee and networking |
|
08.30 |
Welcome and introduction |
|
|
THEME V: Somatic and psychiatric disorders and how they affect claims |
|
08.40 |
Somatoform disorders: Concepts, consequences and treatments
|
|
09.10 |
Case study in handling burn-out claims
|
|
09.40 |
Q&A with Per Fink and Pia Cox |
|
10.00 |
Coffee break |
|
|
THEME VI: Changing risk landscape with ageing populations |
|
10.30 |
Who are the ageing and who pays for them?
|
|
11.00 |
Underwriting older ages
|
|
11.30 |
Latest insights into research and therapies of Alzheimer and other neurodegenerative diseases
|
|
12.00 |
Closing remarks |
|
12.15 |
Optional buffet lunch |
|
13.15 |
End |
This event may be photographed, filmed and/or recorded. A summary of the event, pictures and/or a video of the event in which you may appear may be posted and made available on Swiss Re’s and the Swiss Re Institute's internal and external websites and in printed materials.
tab4
tab5
Following the success of the Insurance Medicine Summits in 2012 and 2014, our 3rd Insurance Medicine Summit took place on 15 - 17 November 2017, at the Swiss Re Centre for Global Dialogue near Zurich. Chief Medical Officers, Chief L&H Underwriters and Claims Managers of global insurers discussed the latest medical trends and advances together with leading academics, clinicians and researchers.
At the conference, we explored a wide spectrum of the latest research and developments in insurance medicine. Amongst the topics addressed was the paradigm shift in type 2 diabetes, the latest trends in cancer diagnostics and therapies, the risks and needs for an ageing population as well as the impact of new technologies on product innovation.
The programme was being set up in collaboration with medical officers across different continents. It will provide a unique platform, providing participants with tangible and practical information of direct relevance to their daily work, as well as their companies' guidelines and products.
John Schoonbee
Global Chief Medical Officer
Swiss Reinsurance Company Ltd
tab6
Brian Ivanovic
Manager & Sr Researcher Applied R&D
Life & Health Products
Domenico Savarese
Head L&H Products Strategy
Life & Health Products
John Schoonbee
Global Chief Medical Officer
Life & Health Products
Daniel Thyssen
L&H IT Business Partner EMEA
Information Technology
Urs Widmer
Senior Life Guide Medical Officer
Life & Health Products
Monica Wilson
Chief Medical Officer
Life & Health Products
Hector Wong
Senior Regional Medical Officer
Life & Health Products
Kelvyn Young
Head L&H Partnerships
Life & Health Products
Nicola Aceto
Group Leader
Department of Biomedicine, Cancer Metastasis, University of Basel
Pia Cox
Medical Manager Health Care
AG Insurance
Duncan Dymond
Consultant Cardiologist
London
Per Fink
Head of Research and Chief Physician
The Research Clinic for Functional Disorders, Aarhus University Hospital
Jason Fung
Medical Director
Intensive Dietary Management (IDM) Program
Zoë Harcombe
Independent author, researcher and speaker
Diet, health and nutrition
Martin Jinek
Assistant Professor
Department of Biochemistry, University of Zurich
Aseem Malhotra
Consultant Cardiologist and Member
Academy Of Medical Royal Colleges Obesity Steering Group
Ulf Petrausch
Immunologist and Oncologist
Oncology Centre Hirslanden
David Unwin
Senior Partner
Fellow of the Royal College of General Practitioners and Norwood Surgery
Nicholas Wood
Principal Investigator
UCL